CONCLUSIONS: Labia majora flap scrotoplasty via a bilateral rotational advancement technique and perineal reconstruction can be safely done during or after phalloplasty. Minor wound complications are common and frequently heal with conservative management. Wounds that do not heal are often associated with a urethral complication. Hematomas of the scrotum and perineum are rare.
INTRODUCTION:
Despite the medical necessity, legislative mandates, and economic benefits of gender-affirming surgery, access to treatment remains limited. World Professional Association for Transgender Health (WPATH) has proposed guidelines for transition-related surgery in conjunction with criteria to delineate medical necessity. We assessed insurance coverage of "top" gender-affirming surgery and evaluated the differences between insurance policy criteria and WPATH recommendations.
METHODS:
We conducted a cross-sectional analysis of insurance policies for coverage of top gender-affirming surgery. Insurance companies were selected based on their state enrolment data and market share. A web-based search and individual telephone interviews were conducted to identify the policy. Medical necessity criteria were abstracted from publicly available policies.
RESULTS:
Of the 57 insurers evaluated, bilateral mastectomy (female-to-male) was covered by significantly more insurers than breast augmentation (male-to-female) (96% versus 68%; P < 0.0001). Only 4% of companies used WPATH-consistent criteria. No criterion was universally required by insurers. Additional prerequisites for coverage that extended beyond WPATH guidelines for top surgery were continuous living in congruent gender role, 2 referring mental health professionals, and hormone therapy before surgery. Hormone therapy was required in a significantly higher proportion of male-to-female policies compared to female-to-male policies (90% versus 21%; P < 0.0001).
CONCLUSION:
In addition to the marked intercompany variation in criteria for insurance coverage which often deviated from WPATH recommendations, there are healthcare insurers who categorically deny access to top gender-affirming surgery. A greater evidence base is
